Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus

Vaccine

Volumn 28, Issue 17, 2010, Pages 3047-3054

  Stewart, M ^a   Bhatia, Y ^a   Athmaran, T N ^a   Noad, R ^a   Gastaldi, C ^b   Dubois, E ^b   Russo, P ^b   Thiery R ^b   Sailleau, C ^b   Breard E ^c   Zientara, S ^c   Roy, P ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Healthy Pigs Production and Experimentation Section   (France)

^c ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

Author keywords

Baculovirus expression; Bluetongue virus; Virus like particles

Indexed keywords

VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLUETONGUE; BLUETONGUE ORBIVIRUS; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG SAFETY; FEMALE; IMMUNOGENICITY; MALE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHEEP; VACCINATION; VACCINE PRODUCTION; VALIDATION STUDY; VIRUS LIKE AGENT;

ANIMALS; BACULOVIRIDAE; BLUETONGUE VIRUS; CELL LINE; CLONING, MOLECULAR; CRICETINAE; FEMALE; GENE EXPRESSION; GENETIC VECTORS; MALE; SHEEP; VACCINES, VIROSOME; VIRAL PROTEINS; VIRAL VACCINES; VIREMIA; VIROSOMES;

EID: 77949656258     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.072     Document Type: Article

References (43)

1. OIE. Notifiable diseases list (2009), World Organisation for Animal Health
2. Mellor P.S., Carpenter S., Harrup L., Baylis M., and Mertens P.P. Bluetongue in Europe and the Mediterranean Basin: history of occurrence prior to 2006. Prev Vet Med 87 1-2 (2008) 4-20
3. Purse B.V., Mellor P.S., Rogers D.J., Samuel A.R., Mertens P.P., and Baylis M. Climate change and the recent emergence of bluetongue in Europe. Nat Rev Microbiol 3 2 (2005) 171-181
4. Schwartz-Cornil I., Mertens P.P., Contreras V., Hemati B., Pascale F., Breard E., et al. Bluetongue virus: virology, pathogenesis and immunity. Vet Res 39 5 (2008) 46
5. Backx A., Heutink C.G., van Rooij E.M., and van Rijn P.A. Clinical signs of bluetongue virus serotype 8 infection in sheep and goats. Vet Rec 161 17 (2007) 591-592
6. Toussaint J.F., Sailleau C., Mast J., Houdart P., Czaplicki G., Demeestere L., et al. Bluetongue in Belgium, 2006. Emerg Infect Dis 13 4 (2007) 614-616
7. Wouda W., Roumen M.P., Peperkamp N.H., Vos J.H., van Garderen E., and Muskens J. Hydranencephaly in calves following the bluetongue serotype 8 epidemic in the Netherlands. Vet Rec 162 13 (2008) 422-423
8. Stott J.L., Oberst R.D., Channell M.B., and Osburn B.I. Genome segment reassortment between two serotypes of bluetongue virus in a natural host. J Virol 61 9 (1987) 2670-2674
9. Batten C.A., Maan S., Shaw A.E., Maan N.S., and Mertens P.P. A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment. Virus Res 137 1 (2008) 56-63
10. Schultz G., and Delay P.D. Losses in newborn lambs associated with bluetongue vaccination of pregnancy ewes. J Am Vet Med Assoc 127 942 (1955) 224-226
11. Young S., and Cordy D.R. An ovine fetal encephalopathy caused by bluetongue vaccine virus. J Neuropathol Exp Neurol 23 (1964) 635-659
12. Osburn B.I., Johnson R.T., Silverstein A.M., Prendergast R.A., Jochim M.M., and Levy S.E. Experimental viral-induced congenital encephalopathies. II. The pathogenesis of bluetongue vaccine virus infection in fetal lambs. Lab Invest 25 3 (1971) 206-210
13. Eschbaumer M., Hoffmann B., Konig P., Teifke J.P., Gethmann J.M., Conraths F.J., et al. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep. Vaccine (2009)
14. Gethmann J., Huttner K., Heyne H., Probst C., Ziller M., Beer M., et al. Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions. Vaccine 27 31 (2009) 4118-4126
15. Roy P., and Noad R. Bluetongue virus assembly and morphogenesis. Curr Top Microbiol Immunol 309 (2006) 87-116
16. Wilson A., and Mellor P. Bluetongue in Europe: vectors, epidemiology and climate change. Parasitol Res 103 Suppl. 1 (2008) S69-S77
17. Carpenter S., Wilson A., and Mellor P.S. Culicoides and the emergence of bluetongue virus in northern Europe. Trends Microbiol 17 4 (2009) 172-178
18. Hassan S.S., and Roy P. Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry. J Virol 73 12 (1999) 9832-9842
19. Inumaru S., and Roy P. Production and characterization of the neutralization antigen VP2 of bluetongue virus serotype 10 using a baculovirus expression vector. Virology 157 2 (1987) 472-479
20. Mecham J.O., Dean V.C., and Jochim M.M. Correlation of serotype specificity and protein structure of the five U.S. serotypes of bluetongue virus. J Gen Virol 67 Pt 12 (1986) 2617-2624
21. Huismans H., and Erasmus B.J. Identification of the serotype-specific and group-specific antigens of bluetongue virus. Onderstepoort J Vet Res 48 2 (1981) 51-58
22. Huismans H., van der Walt N.T., Cloete M., and Erasmus B.J. Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep. Virology 157 1 (1987) 172-179
23. Roy P., Urakawa T., Van Dijk A.A., and Erasmus B.J. Recombinant virus vaccine for bluetongue disease in sheep. J Virol 64 5 (1990) 1998-2003
24. Hewat E.A., Booth T.F., and Roy P. Structure of correctly self-assembled bluetongue virus-like particles. J Struct Biol 112 3 (1994) 183-191
25. French T.J., Marshall J.J., and Roy P. Assembly of double-shelled, virus-like particles of bluetongue virus by the simultaneous expression of four structural proteins. J Virol 64 12 (1990) 5695-5700
26. Roy P., French T., and Erasmus B.J. Protective efficacy of virus-like particles for bluetongue disease. Vaccine 10 1 (1992) 28-32
27. Roy P., Bishop D.H., LeBlois H., and Erasmus B.J. Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. Vaccine 12 9 (1994) 805-811
28. Loudon P.T., Hirasawa T., Oldfield S., Murphy M., and Roy P. Expression of the outer capsid protein VP5 of two bluetongue viruses, and synthesis of chimeric double-shelled virus-like particles using combinations of recombinant baculoviruses. Virology 182 2 (1991) 793-801
29. Kitts P.A., and Possee R.D. A method for producing recombinant baculovirus expression vectors at high frequency. Biotechniques 14 5 (1993) 810-817
30. In: Sambrook J., and Russell D.W. (Eds). Molecular Cloning. A Laboratory Manual. 3rd ed. (2001), Cold Spring Harbour Laboratory Press, New York
31. Weyer U., and Possee R.D. Analysis of the promoter of the Autographa californica nuclear polyhedrosis virus p10 gene. J Gen Virol 70 Pt 1 (1989) 203-208
32. Belyaev A.S., and Roy P. Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells. Nucleic Acids Res 21 5 (1993) 1219-1223
33. Emery V.C., and Bishop D.H. The development of multiple expression vectors for high level synthesis of eukaryotic proteins: expression of LCMV-N and AcNPV polyhedrin protein by a recombinant baculovirus. Protein Eng 1 4 (1987) 359-366
34. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 5259 (1970) 680-685
35. French T.J., and Roy P. Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV. J Virol 64 4 (1990) 1530-1536
36. Marshall J.J., and Roy P. High level expression of the two outer capsid proteins of bluetongue virus serotype 10: their relationship with the neutralization of virus infection. Virus Res 15 3 (1990) 189-195
37. van der Walt N.T. A haemagglutination and haemagglutination inhibition test for bluetongue virus. Onderstepoort J Vet Res 47 2 (1980) 113-117
38. Perrin A., Albina E., Breard E., Sailleau C., Prome S., Grillet C., et al. Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants. Vaccine 25 37-38 (2007) 6774-6783
39. Roy P., Boyce M., and Noad R. Prospects for improved bluetongue vaccines. Nat Rev Microbiol 7 2 (2009) 120-128
40. Boone J.D., Balasuriya U.B., Karaca K., Audonnet J.C., Yao J., He L., et al. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 25 4 (2007) 672-678
41. Veronesi E., Hamblin C., and Mellor P.S. Live attenuated bluetongue vaccine viruses in Dorset Poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae). Vaccine 23 48-49 (2005) 5509-5516
42. Ferrari G., De Liberato C., Scavia G., Lorenzetti R., Zini M., Farina F., et al. Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy. Prev Vet Med 68 2-4 (2005) 103-113
43. Adkison M.A., Stott J.L., and Osburn B.I. Temporal development of bluetongue virus protein-specific antibody in sheep following natural infection. Vet Microbiol 16 3 (1988) 231-241